We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+9.16%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.79B
AUM Growth
+$493M
Cap. Flow
+$186M
Cap. Flow %
3.21%
Top 10 Hldgs %
23.53%
Holding
286
New
43
Increased
91
Reduced
94
Closed
31

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$52.9M
2
CNQ icon
Canadian Natural Resources
CNQ
+$43.8M
3
ABT icon
Abbott
ABT
+$37.3M
4
AMGN icon
Amgen
AMGN
+$35M
5
AME icon
Ametek
AME
+$28.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$66.2M
2
N
Netsuite Inc
N
+$40M
3
AGN
Allergan plc
AGN
+$39.6M
4
BMY icon
Bristol-Myers Squibb
BMY
+$38.9M
5
BCR
CR Bard Inc.
BCR
+$33.3M

Sector Composition

Rank Sector Weight
1 Technology 21.6%
2 Healthcare 21.19%
3 Financials 20.46%
4 Communication Services 9.97%
5 Consumer Discretionary 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPA icon
201
Copa Holdings
CPA
$5.56B
$2.08M 0.04%
+23,688
New +$1.8M
BDX icon
202
Becton Dickinson
BDX
$43.1B
$2.07M 0.04%
11,788
-95,837
-89% -$16.4M
HR
203
DELISTED
Healthcare Realty Trust Incorporated
HR
$2.04M 0.04%
60,000
– –
NMFC icon
204
New Mountain Finance
NMFC
$646M
$2.03M 0.04%
147,500
– –
NHI icon
205
National Health Investors
NHI
$3.9B
$1.96M 0.03%
25,000
– –
SUPN icon
206
Supernus Pharmaceuticals
SUPN
$2.68B
$1.92M 0.03%
77,500
-33,025
-30% -$747K
MTLS
207
Materialise
MTLS
$379M
$1.9M 0.03%
246,790
+79,799
+48% +$555K
SBRA icon
208
Sabra Healthcare REIT
SBRA
$5.64B
$1.89M 0.03%
75,000
– –
MON
209
DELISTED
Monsanto Co
MON
$1.82M 0.03%
17,797
-18,557
-51% -$1.95M
OHI icon
210
Omega Healthcare
OHI
$15.4B
$1.77M 0.03%
50,000
– –
NSTG
211
DELISTED
NanoString Technologies, Inc.
NSTG
$1.62M 0.03%
81,000
-19,000
-19% -$302K
VRTX icon
212
Vertex Pharmaceuticals
VRTX
$121B
$1.61M 0.03%
18,500
-11,181
-38% -$1.06M
WBA
213
DELISTED
Walgreens Boots Alliance
WBA
$1.61M 0.03%
20,000
-300,000
-94% -$24.5M
NGD
214
DELISTED
New Gold Inc
NGD
$1.6M 0.03%
362,611
-400,337
-52% -$2M
HCSG icon
215
Healthcare Services Group
HCSG
$1.56B
$1.52M 0.03%
38,372
– –
HCA icon
216
HCA Healthcare
HCA
$84.8B
$1.51M 0.03%
20,000
-301,027
-94% -$23M
PCRX icon
217
Pacira BioSciences
PCRX
$1.02B
$1.17M 0.02%
34,100
-14,096
-29% -$552K
TSLA icon
218
Tesla
TSLA
$1.24T
$1.16M 0.02%
85,200
-51,000
-37% -$736K
HDB icon
219
HDFC Bank
HDB
$119B
$1.13M 0.02%
63,068
– –
BKD icon
220
Brookdale Senior Living
BKD
$3.62B
$1.05M 0.02%
60,000
+32,981
+122% +$569K
JAZZ icon
221
Jazz Pharmaceuticals
JAZZ
$15.9B
$1.03M 0.02%
8,500
-172,385
-95% -$23.2M
AUY
222
DELISTED
Yamana Gold, Inc.
AUY
$912K 0.02%
205,575
-491,425
-71% -$2.53M
VIVO
223
DELISTED
Meridian Bioscience Inc
VIVO
$860K 0.01%
44,600
+1,800
+4% +$35.2K
RCKT icon
224
Rocket Pharmaceuticals
RCKT
$348M
$711K 0.01%
18,750
+1,824
+11% +$57.4K
AKAO
225
DELISTED
Achaogen Inc
AKAO
$695K 0.01%
145,000
+45,000
+45% +$180K
7 8
9
10 11

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Polar Capital held 286 positions worth $5.79B, up 9.3% from $5.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $186M of net new capital in Q3 2016, opening 43 new positions and adding to 91 existing holdings. Its largest new stake was Canadian Natural Resources: 2,876,960 shares worth $52.7M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Pfizer, an estimated $66.2M trimmed.

  • Polar Capital's largest Q3 2016 buy was Canadian Natural Resources: 2,876,960 shares worth $52.7M.
  • Polar Capital added most to Merck in Q3 2016, an estimated $52.9M increase.
  • Polar Capital's biggest Q3 2016 reduction was Pfizer, cutting an estimated $66.2M.
  • Polar Capital fully exited Allergan plc in Q3 2016, selling an estimated $39.6M.
  • Polar Capital's ten largest holdings make up 24% of its $5.79B portfolio in Q3 2016.
  • Polar Capital opened 43 new positions and closed 31 in Q3 2016.
  • Polar Capital's portfolio value rose 9.3% quarter-over-quarter to $5.79B.

Based on Polar Capital's 13F filing for Q3 2016, filed 14 Nov 2016.